GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
AbbVie (ABBV) [hlAlert]

Rating:
Buy ABBV
up 44.86 %

AbbVie (ABBV) rated Buy with price target $59 by Argus

Posted on: Tuesday,  Oct 29, 2013  8:25 AM ET by Argus

Argus rated Buy AbbVie (NYSE: ABBV) on 10/29/2013. Previously Argus rated Buy AbbVie (NYSE: ABBV) on 08/12/2013., when the
stock price was $44.53. Since then, AbbVie has gained 44.87% as of 12/01/2015's recent price of $64.51.
If you would have followed the previous Argus's recommendation on ABBV, you would have gained 44.86% of your investment in 841 days.



Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/26/2014 8:25 AM Buy
None
68.32 85.00
as of 12/13/2013
1 Week up  1.98 %
1 Month up  9.44 %
3 Months up  16.66 %
1 YTD up  5.56 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/29/2013 8:25 AM Buy
None
49.61 59.00
8/12/2013 8:25 AM Buy
None
44.53 52.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy